PRESS RELEASE published on 10/19/2023 at 15:57, 2 years 9 months ago Original-Research: Sernova Corp (von First Berlin Equity Research GmbH): BUY
PRESS RELEASE published on 09/14/2023 at 22:06, 2 years 10 months ago Sernova Investor Conference Call Previously Scheduled for September 15 Now Rescheduled for September 22
PRESS RELEASE published on 09/13/2023 at 13:01, 2 years 10 months ago Sernova to Host Investor Calls to Introduce Newly Appointed CEO and Provide Business Update
PRESS RELEASE published on 05/03/2023 at 13:01, 3 years 3 months ago Sernova Announces Research Collaboration with AstraZeneca to Evaluate Novel Potential Therapeutic Cell Applications
PRESS RELEASE published on 04/10/2023 at 13:05, 3 years 4 months ago Sernova to Present at 2023 Alliance for Regenerative Medicine Cell & Gene Meeting on the Med
PRESS RELEASE published on 03/22/2023 at 12:04, 3 years 4 months ago Sernova: Abstract on First Cohort of its Phase 1/2 Study Involving Islet Transplantation into Cell Pouch Selected for Oral Podium Presentation at American Diabetes Association 83rd Scientific Sessions
PRESS RELEASE published on 03/14/2023 at 12:05, 3 years 4 months ago Sernova Announces Upcoming Podium Presentation of iPSC and Cell Pouch™ Combination Treatment for Type One Diabetes at the 4th IPITA / HSCI / JDRF Summit
PRESS RELEASE published on 03/08/2023 at 13:05, 3 years 5 months ago Sernova Announces Initial Islet Transplantation in First Two Patients Enrolled in Second Cohort of its U.S. Phase 1/2 Clinical Trial for Treatment of Type 1 Diabetes
PRESS RELEASE published on 03/02/2023 at 13:05, 3 years 5 months ago Sernova to Participate in Upcoming Roth and Oppenheimer Investor Conferences
PRESS RELEASE published on 01/30/2023 at 13:35, 3 years 6 months ago Sernova Announces Advancements with its Novel Cell Pouch System(TM) to Preserve Thyroid Function Following Total Thyroidectomy
Published on 08/12/2026 at 23:30, 10 minutes ago CCL Industries Announces Record Results for 2026 Second Quarter
Published on 08/12/2026 at 23:20, 20 minutes ago RJK Explorations Ltd. Announces Upsize of Previously Announced Private Placement
Published on 08/12/2026 at 23:05, 35 minutes ago Vox Royalty Reports Q2 2026 Results And Declares Quarterly Dividend
Published on 08/12/2026 at 22:01, 1 hour 39 minutes ago Fermi Names Lee McIntire as Chief Executive Officer
Published on 08/12/2026 at 15:42, 7 hours 58 minutes ago Critical Elements 10,000-Meter Summer Drill Program at Rose West Resumes with Positive Results
Published on 08/12/2026 at 21:05, 2 hours 34 minutes ago Aurisco Pharmaceutical is the First Generic Oligonucleotide Manufacturer in the World successfully inspected by USFDA
Published on 08/12/2026 at 19:57, 3 hours 42 minutes ago EQS-Adhoc: Hypoport SE: Hypoport SE resolves share buyback programme with a volume of up to EUR 10 million
Published on 08/12/2026 at 19:37, 4 hours 2 minutes ago EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for H1 2026 at €13.4 million and adjusted EBITDA at €-0.5 million; forecast for the continuing operations unchanged
Published on 08/11/2026 at 17:45, 1 day 5 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 6 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 5 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 5 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
